Loading...
NPI 1679526800 · Fort Collins, CO · Radiology Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
E Plus Pet Imaging Xviii LP is a radiology clinic/center provider located in Fort Collins, Colorado. This profile covers 5 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | E Plus Pet Imaging Xviii LP |
| Address | 1915 Wilmington Dr |
| City | Fort Collins |
| State | CO |
| ZIP | 80528 |
| Taxonomy | Radiology Clinic/Center |
| NPI Enumerated | May 18, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.1M |
| Medicaid | $964.4K |
This provider generates $2.1M in lifetime Medicare revenue and $964.4K in lifetime Medicaid revenue, indicating Medicare is the larger payer relationship on file while Medicaid represents a substantial secondary source of billings. The practice is recorded as a Radiology Clinic/Center and its revenue scale is concentrated in diagnostic imaging services rather than a broad mix of outpatient care.
Clinical and service-line profile is tightly focused on PET/CT imaging and radiopharmaceutical diagnostics: Medicare top codes include 78815 (PET/CT) with 1.5K claims and $1M revenue, A9595 (piflufolastat f-18) with 1.1K claims and $790K revenue, and 78816 (PET imaging) with 203 claims and $133.8K revenue. This mix—plus notable A9552 (FDG) activity—signals an operation that primarily provides high-volume PET scans and onsite radiotracer administration rather than a general diagnostic imaging portfolio.
Revenue concentration is extreme for both payers: the precomputed top-3 Medicare codes account for 92.8% of this provider's total Medicare revenue, and the precomputed top-3 Medicaid codes account for 100.0% of this provider's total Medicaid revenue. For Medicare the two largest individual drivers are 78815 (48.8% of Medicare revenue) and A9595 (37.7% of Medicare revenue), showing most earnings come from a very small set of services.
National competitive standing on Medicare shows clear prominence for specific PET services: 78815 ranks #6 of 6566 providers nationally (100th percentile; extreme outlier), A9595 ranks #29 of 528 providers nationally (95th percentile; notably above typical national volume), and A9552 ranks #26 of 2411 providers nationally (99th percentile; extreme outlier). These rank/percentile positions indicate the provider is a major national-volume site for multiple PET-related codes rather than a modest participant.
On Medicaid within Colorado the provider is the top in-state biller for the leading PET services: 78815 has 1.7K claims and $881.2K revenue (91.3% of the provider's Medicaid revenue) and ranks #1 of 16 providers in-state (100th percentile; notably above typical state volume), while A9552 has 1.2K claims and $84K revenue (8.7% of Medicaid revenue) and ranks #1 of 10 providers in-state (100th percentile; notably above typical state volume). These patterns show the provider effectively dominates Medicaid PET billing in its state.
Not all radiopharmaceutical lines are unusually concentrated: A9587 (Gallium ga-68, dotatate) accounts for $87.6K of Medicare revenue (4.2% of Medicare revenue) across 674 claims and ranks #41 of 77 providers nationally (47th percentile; typical, unremarkable volume). This suggests the business is selective in high-volume tracers—very large for FDG and piflufolastat but typical for some specialty agents like Ga-68 dotatate.
The provider has an established operational history with its NPI enumerated on 2006-05-18 (~20 years ago), consistent with sustained specialty imaging capacity and the ability to build referral streams for PET/CT and associated tracer services over time. Longevity plus concentrated high-volume billing supports classification as an experienced, specialized PET imaging center rather than a new entrant.
For payers and network analysts, the combination of high per-claim payments on Medicare-listed imaging (e.g., $660 avg for 78815 and $706 avg for A9595) and heavy revenue concentration (92.8% Medicare; 100.0% Medicaid) flags utilization and cost exposure that is concentrated in a few procedures. Given the provider's outlier status on multiple PET codes, payers should expect material impact from any changes in utilization, reimbursement, or radiopharmaceutical availability and may prioritize contract, utilization management, or site-of-service strategies for these specific codes.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 1,550 | $660 | $1M |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 1,120 | $710 | $790K |
| 78816 | The patient is injected with a radiopharmaceutical tracer called FDG (fluoro–deoxyglucose, a radioactive substance containing glucose) about one hour before the imaging is scheduled to begin. The… | 200 | $660 | $133.8K |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 670 | $130 | $87.6K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 690 | $90 | $62.7K |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 5 CPT/HCPCS codes.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 1,710 | $520 | $881.2K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,240 | $70 | $84K |
How this provider's Medicaid billing volume and revenue compare to other Colorado providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Colorado median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 1 | 20 | 100 | $270 | $110.5K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1 | 10 | 30 | $70 | $11.8K |
Other providers in the same ZIP code as E Plus Pet Imaging Xviii LP, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Harmony Surgery Center, LLC | CO | Ambulatory Surgical Clinic/Center | $5.4M | $2.8M |
| Noco Pediatric Ot, LLC | CO | Occupational Therapist | $0 | $5.7M |
| Tender Care Pediatric Services, Inc | CO | In Home Supportive Care Agency | $0 | $5.4M |
| Surgery Center Of Northern Colorado | CO | Ambulatory Surgical Clinic/Center | $4.3M | $702.8K |
| Charles Sisson | CO | Pain Medicine (Anesthesiology) Physician | $2.6M | $0 |
| Matthew Asano | CO | Ophthalmology Physician | $2M | $0 |
| Michael Thakor | CO | Rheumatology Physician | $1.8M | $0 |
| Harmony Imaging Center LLC | CO | Diagnostic Radiology Physician | $1.1M | $417.9K |
| Tamara Miller | CO | Specialist | $1.4M | $0 |
| Joshua Petit | CO | Radiation Oncology Physician | $443.5K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.